Pediatric Data Concerns Can’t Derail US CDC’s Universal ’23-’24 COVID Vaccine Recommendation

FDA approval was swiftly followed by CDC advisory committee recommendation of the XBB.1.5. variant-based vaccines for all people aged 6 months and older.

pediatric vaccination — • Source: Shutterstock

Following an efficient one-two regulatory punch by the US Centers for Disease Control & Prevention and the US FDA, 2023-2024 COVID-19 vaccines based on the Omicron variant XBB.1.5 will be available later in the week with a recommendation for use by everyone 6 months of age and older.

The FDA approved and authorized the Moderna and Pfizer/BioNTech 2023-2024 COVID-19 vaccines on 11 September, conveniently one day before the...